Skip to content

Isomorphic Labs vs Lila Sciences

A side-by-side comparison of Isomorphic Labs and Lila Sciences, two Science tools, drawn from Ignaite's continuously-verified listings.

Compared from listings verified as of

Isomorphic Labs

Science

AI-first drug design built on AlphaFold for pharma R&D.

View Isomorphic Labs

Lila Sciences

Science

Autonomous AI labs pursuing scientific superintelligence.

View Lila Sciences

At a glance

Feature comparison of Isomorphic Labs and Lila Sciences
AttributeIsomorphic LabsLila Sciences
CategoryScienceScience
PricingPAIDPAID
LicenseProprietaryProprietary
DeploymentCloudCloud
PlatformsWebWeb
Model support
Vendor (differs)Isomorphic LabsLila Sciences
Capabilities (differs)
  • Protein structure prediction
  • Molecular design
  • Autonomous research
  • Materials discovery
  • Drug target discovery

The honest brief

Isomorphic Labs

Direct lineage to Nobel-winning AlphaFold plus Alphabet backing — few AI-drug shops pair that model pedigree with deep-pocket pharma partnerships.

  • AlphaFold-derived design models
  • Alphabet-backed capital
  • Top-pharma partnerships
  • Nobel-laureate leadership
  • Pharma partnerships only
  • No public product or API
  • No approved drug yet
  • Opaque pricing

Lila Sciences

A domain-agnostic autonomous 'AI + robotic lab' loop spanning materials, chemicals, and therapeutics — broader than the protein/drug-only focus of peers.

  • Autonomous experiment loop
  • Cross-domain (materials to therapeutics)
  • Flagship Pioneering-backed
  • Pairs AI model with robotic lab instruments
  • Partnership-only engagement
  • No public product or API
  • 'Superintelligence' claims unproven
  • Opaque pricing

When to pick which

Pick Isomorphic Labs if you need Protein structure prediction and Molecular design.

  • Protein structure prediction (primary capability)
  • Molecular design (secondary capability)

Pick Lila Sciences if you need Autonomous research, Materials discovery, and Drug target discovery.

  • Autonomous research (primary capability)
  • Materials discovery (primary capability)
  • Drug target discovery (secondary capability)